Weber D, Zimmerman K, Tartof S, McLaughlin J, Pather S
Vaccines (Basel). 2024; 12(9).
PMID: 39340021
PMC: 11435672.
DOI: 10.3390/vaccines12090989.
Milan M, Molina A, Ong-Lim A, Uy M, Uy H
Acta Med Philipp. 2024; 58(7):73-89.
PMID: 38882911
PMC: 11168956.
DOI: 10.47895/amp.v58i7.8392.
Yamaguchi F, Suzuki A, Hashiguchi M, Kondo E, Maeda A, Yokoe T
Infect Drug Resist. 2024; 17:161-170.
PMID: 38260181
PMC: 10802122.
DOI: 10.2147/IDR.S432198.
Mansour Ghanaie R, Boone I, Shamshiri A, Karimi A, Amirali A, Marhamati N
Microorganisms. 2023; 11(7).
PMID: 37512845
PMC: 10386463.
DOI: 10.3390/microorganisms11071672.
Messiah S, Swartz M, Abbas R, Talebi Y, Kohl 3rd H, Valerio-Shewmaker M
Children (Basel). 2023; 10(5).
PMID: 37238366
PMC: 10217706.
DOI: 10.3390/children10050818.
Characterisation of infection-induced SARS-CoV-2 seroprevalence amongst children and adolescents in North Carolina.
Ahmed A, DeWitt M, Dantuluri K, Castri P, Buahin A, Lagarde W
Epidemiol Infect. 2023; 151:e63.
PMID: 37009915
PMC: 10154644.
DOI: 10.1017/S0950268823000481.
SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May-July 2021.
OBrien S, Cole L, Albanese B, Mahon A, Knight V, Williams N
Emerg Infect Dis. 2023; 29(5):929-936.
PMID: 36972709
PMC: 10124638.
DOI: 10.3201/eid2905.221541.
SARS-CoV-2 antibody prevalence in a pediatric cohort of unvaccinated children in Mérida, Yucatán, México.
Ayora-Talavera G, D Kirstein O, Puerta-Guardo H, Barrera-Fuentes G, Ortegon-Abud D, Che-Mendoza A
PLOS Glob Public Health. 2023; 2(6):e0000354.
PMID: 36962356
PMC: 10021704.
DOI: 10.1371/journal.pgph.0000354.
Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.
Brown T, de Salazar Munoz P, Bhatia A, Bunda B, Williams E, Bor D
BMJ Open. 2023; 13(3):e061840.
PMID: 36882240
PMC: 10008195.
DOI: 10.1136/bmjopen-2022-061840.
Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic.
Wouambo R, Djuikoue C, Esemu L, Kagoue Simeni L, Tchitchoua M, Djouela Djoulako P
Viruses. 2023; 15(2).
PMID: 36851621
PMC: 9966400.
DOI: 10.3390/v15020407.
Monitoring of Auditory Function in Newborns of Women Infected by SARS-CoV-2 during Pregnancy.
Apa E, Presutti M, Rossi C, Roversi M, Neri S, Gargano G
Children (Basel). 2023; 10(2).
PMID: 36832324
PMC: 9954415.
DOI: 10.3390/children10020194.
Missing science: A scoping study of COVID-19 epidemiological data in the United States.
Bhatia R, Sledge I, Baral S
PLoS One. 2022; 17(10):e0248793.
PMID: 36223335
PMC: 9555641.
DOI: 10.1371/journal.pone.0248793.
Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children.
Ahmed A, Rossman W, Lu L, Dunn C, Harris A, Priem J
Open Forum Infect Dis. 2022; 9(9):ofac459.
PMID: 36193228
PMC: 9494384.
DOI: 10.1093/ofid/ofac459.
Seroprevalence of SARS-CoV-2 among Children Visiting a Tertiary Hospital during the Prevaccination Period, Southwest Region, Saudi Arabia.
Asseri A, Alsabaani A
Vaccines (Basel). 2022; 10(8).
PMID: 36016232
PMC: 9415489.
DOI: 10.3390/vaccines10081344.
SARS-CoV-2 infections in infants in Haiti 2020-2021; evidence from a seroepidemiological cohort.
Louis R, Pu R, Logan T, Trimmer-Smith L, Chamblain R, Gallagher A
PLoS One. 2022; 17(8):e0273482.
PMID: 36006976
PMC: 9409576.
DOI: 10.1371/journal.pone.0273482.
Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil.
Andreata-Santos R, Machado R, Alves R, Sales N, Soares C, Bitencourt Rodrigues K
Front Cell Infect Microbiol. 2022; 12:787411.
PMID: 35719329
PMC: 9202673.
DOI: 10.3389/fcimb.2022.787411.
Clinical characteristics and risk factors for COVID-19 infection and disease severity: A nationwide observational study in Estonia.
Meister T, Pisarev H, Kolde R, Kalda R, Suija K, Milani L
PLoS One. 2022; 17(6):e0270192.
PMID: 35709192
PMC: 9202832.
DOI: 10.1371/journal.pone.0270192.
Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020-February 2021.
Hobbs C, Kim S, Vemula P, Inagaki K, Harrison V, Malloch L
Pediatr Infect Dis J. 2022; 41(9):736-741.
PMID: 35703309
PMC: 9359681.
DOI: 10.1097/INF.0000000000003593.
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021.
Sorg A, Bergfeld L, Jank M, Corman V, Semmler I, Goertz A
Nat Commun. 2022; 13(1):3128.
PMID: 35668073
PMC: 9170697.
DOI: 10.1038/s41467-022-30482-6.
Comparison of SARS-CoV-2 Antibodies and Six Immunoassays in Pediatric and Adult Patients 12 Weeks After COVID-19.
Saglik I, Turkkan A, Turan C, Kara A, Akalin H, Ener B
Cureus. 2022; 14(2):e22195.
PMID: 35308741
PMC: 8924986.
DOI: 10.7759/cureus.22195.
